Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03426384 · ClinicalTrials.gov registry record · NA
FLARE Lupus Research Study Systemic Lupus Erythematosus
A NA study of System; Lupus Erythematosus, sponsored by Mymee.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03426384: Completed NA study of System; Lupus Erythematosus, sponsored by Mymee.
NCT03426384 is a NA study of System; Lupus Erythematosus that has completed, run by Mymee. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03426384, a NA study of System; Lupus Erythematosus, has completed, sponsored by Mymee.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The first phase of this pilot study will assess changes in quality of life at the end of a 16-week Mymee program in patients with moderate to severe SLE. The second phase will assess changes in healthcare utilization and cost over a one year period after program end.
Primary Outcome
BPI-SF is a 9-item questionnaire with two domains: pain severity and pain interference. The pain severity items have values which range from 0 ("no pain") to 10 ("pain as bad as you can imagine"), and the pain interference items have values which range from 0 ("does not interfere") to 10 ("completely interferes"). The pain severity and pain interference domain scores can be calculated as the mean of the scores of their component items.
Conditions Studied
Interventions
- BEHAVIORAL Mymee Program
Study Locations (1)
New York
- Mymee Inc. - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-02-12 |
| Est. Completion | 2019-12-05 |
| Phase | NA |
What the finished NCT03426384 record still lists
NCT03426384 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with System; Lupus Erythematosus appearing as the primary indexed condition, and to 1 intervention - of which Mymee Program is the first listed.
NCT03426384 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03426384 about?
NCT03426384 is a clinical study titled "FLARE Lupus Research Study Systemic Lupus Erythematosus". The first phase of this pilot study will assess changes in quality of life at the end of a 16-week Mymee program in patients with moderate to severe SLE. The second phase will assess changes in healthcare utilization and cost over a one year period after program end.
What is the current status of trial NCT03426384?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2018-02-12. Estimated completion is 2019-12-05.
What conditions does trial NCT03426384 study?
This clinical trial studies the following conditions: System; Lupus Erythematosus.
What interventions are being tested in trial NCT03426384?
The interventions under investigation include: Mymee Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03426384?
This trial is sponsored by Mymee, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03426384 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03426384's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI